Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrating GDF-15 into Multimarker Assessment of Acute Heart Failure: Diagnostic and Prognostic Implications.

Life (Basel, Switzerland)·2026
Same author

Can Endothelin-1 Help Address the Diagnostic and Prognostic Challenges in Multimorbid Acute Heart Failure Patients?

Life (Basel, Switzerland)·2025
Same author

The First Report of <i>mcr</i>-1-Carrying <i>Escherichia coli</i>, Isolated from a Clinical Sample in the North-East of Romania.

Microorganisms·2025
Same author

Insights into Catechin-Copper Complex Structure and Biologic Activity Modulation.

Molecules (Basel, Switzerland)·2024
Same author

Discovery of new molecular hybrid derivatives with coumarin scaffold bearing pyrazole/oxadiazole moieties: Molecular docking, POM analyses, in silico pharmacokinetics and in vitro antimicrobial evaluation with identification of potent antitumor pharmacophore sites.

Bioorganic chemistry·2024
Same author

Development of cream bases suitable for personalized cosmetic products.

Medicine and pharmacy reports·2024

Related Experiment Videos

Cefpirome susceptibility in staphylococci isolates.

Antonia Poiată1, Cristina Tuchiluş, Ioana Bădicuţ

  • 1Disciplina de Microbiologie, Facultatea de Farmacie, Universitatea de Medicină Si Farmacie "Gr. T. Popa", Iaşi.

Revista Medico-Chirurgicala a Societatii De Medici Si Naturalisti Din Iasi
|June 29, 2007
PubMed
Summary

Cefpirome demonstrates strong in vitro activity against staphylococci, showing higher susceptibility rates than oxacillin. This fourth-generation cephalosporin is effective against both coagulase-positive and coagulase-negative staphylococci clinical isolates.

Related Experiment Videos

Area of Science:

  • Microbiology
  • Infectious Diseases

Background:

  • Cefpirome is a fourth-generation cephalosporin antibiotic.
  • It possesses a broad spectrum of activity against Gram-negative and Gram-positive bacteria.
  • Staphylococci are significant human pathogens, necessitating effective antimicrobial agents.

Purpose of the Study:

  • To evaluate the in vitro antimicrobial activity of cefpirome against clinical isolates of staphylococci.
  • To compare the efficacy of cefpirome with oxacillin, a common antistaphylococcal antibiotic.

Main Methods:

  • A total of 434 staphylococcal isolates were tested: 268 coagulase-positive and 166 coagulase-negative.
  • Susceptibility testing was performed using the Mueller-Hinton agar dilution method.
  • Oxacillin was included as a comparator agent.

Main Results:

  • Cefpirome inhibited most staphylococcal strains at concentrations of 0.5-8 mg/l.
  • High susceptibility rates were observed for cefpirome: 91.6% against coagulase-negative staphylococci and 81.3% against coagulase-positive staphylococci.
  • Oxacillin resistance was observed in 35.1% of coagulase-positive and 26.5% of coagulase-negative staphylococci. Cross-resistance between cefpirome and oxacillin was noted.

Conclusions:

  • Cefpirome exhibited superior in vitro activity against staphylococci compared to oxacillin.
  • The findings support cefpirome's potential as a treatment option for staphylococcal infections.